Polymixin-B Hemoperfusion in a Case Intolerant to Conventional Antibiotic Therapy

Journal of Biomedical Science and Engineering
doi 10.4236/jbise.2012.53013
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Scientific Research Publishing, Inc.

Related search

A Guide to Antibiotic Therapy

Journal of Chronic Diseases
1960English

Managing Chronic Myeloid Leukemia Patients Intolerant to Tyrosine Kinase Inhibitor Therapy

Blood Cancer Journal
OncologyHematology
2012English

Septicemia, Necrotizing Fasciitis, and Peritonitis Due to Vibrio Vulnificus Treated With Early Use of Polymyxin B Hemoperfusion in a Patient Undergoing CAPD: A Case Report

BMC Nephrology
Nephrology
2020English

A Complementary Medicine Approach to Augmenting Antibiotic Therapy: Current Practices in the Use of Probiotics During Antibiotic Therapy

International Journal of Complementary & Alternative Medicine
2018English

Polymyxin B Hemoperfusion in High Endotoxin Activity Level Septic Shock Patients

Critical Care
Critical CareIntensive Care Medicine
2008English

A Case of Successful Treatment With Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion in Acute Respiratory Distress Syndrome After Influenza a Infection

Internal Medicine
Internal MedicineMedicine
2011English

Knowing When to Stop Antibiotic Therapy

Medical Journal of Australia
Medicine
2015English

Silent Antibiotic Resistance Genes: A Threat to Antimicrobial Therapy

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2019English

Multiple Drug-Intolerant Hypertension: A Case Series Utilising a Novel-Treatment Algorithm

British Journal of General Practice
MedicineFamily Practice
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy